TARO Company Profile

✉ Email this page to a colleague

TARO has two hundred and fifty-three approved drugs.

There are eight US patents protecting TARO drugs. There are four tentative approvals on TARO drugs.

There are thirty-one patent family members on TARO drugs in twelve countries and one hundred and seventy-three supplementary protection certificates in fourteen countries.

International Patents:	31
US Patents:	8
Tradenames:	133
Ingredients:	116
NDAs:	253
Patent Litigation for TARO:	See patent lawsuits for TARO
PTAB Cases with TARO as petitioner:	See PTAB cases with TARO as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	FLUPHENAZINE HYDROCHLORIDE	fluphenazine hydrochloride	TABLET;ORAL	215674-002	Apr 14, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro Pharm Inds	HYDROCORTISONE BUTYRATE	hydrocortisone butyrate	CREAM;TOPICAL	076654-001	Aug 3, 2005	AB1	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	ONDANSETRON HYDROCHLORIDE	ondansetron hydrochloride	TABLET;ORAL	077729-001	Mar 28, 2011		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	BETAMETHASONE VALERATE	betamethasone valerate	CREAM;TOPICAL	070062-001	May 14, 1985		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Taro	BETAMETHASONE DIPROPIONATE	betamethasone dipropionate	GEL, AUGMENTED;TOPICAL	076508-001	Dec 2, 2003	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-002	Jan 17, 2008	5,881,926	⤷ Try a Trial
Taro	PLIAGLIS	lidocaine; tetracaine	CREAM;TOPICAL	021717-001	Jun 29, 2006	5,919,479	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,399,079	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	6,071,523	⤷ Try a Trial
Taro	FLO-PRED	prednisolone acetate	SUSPENSION;ORAL	022067-001	Jan 17, 2008	5,881,926	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Lotion	0.5%	➤ Subscribe	2011-03-16
➤ Subscribe	Topical Spray	0.25%	➤ Subscribe	2013-12-18

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0328535	96C0021	Belgium	⤷ Try a Trial	PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
0548114	SPC/GB97/064	United Kingdom	⤷ Try a Trial	PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
0617614	2001/009	Ireland	⤷ Try a Trial	PRODUCT NAME: PANRETIN-ALITRETINOIN
2506844	LUC00077	Luxembourg	⤷ Try a Trial	PRODUCT NAME: PRODUIT DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (PAR EXEMPLE LE BROMURE D'UMECLIDINIUM), LE VILANTEROL OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE (PAR EXEMPLE LE TRIFENATATE DE VILANTEROL) ET LE FUROATE DE FLUTICASONE; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117
1620113	C 2015 036	Romania	⤷ Try a Trial	PRODUCT NAME: IVERMECTINA; NATIONAL AUTHORISATION NUMBER: RO7674/2015/01, RO7674/2015/02, RO7674/2015/03, RO7674/2015/04, RO7674/2015/05; DATE OF NATIONAL AUTHORISATION: 20150526; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): MALTA MA117/01101; DATE OF FIRST AUTHORISATION IN EEA: 20150402
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.